C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/09 (2006.01) A61K 39/395 (2006.01) A61P 1/02 (2006.01) A61P 3/14 (2006.01) A61P 19/08 (2006.01) A61P 19/10 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01) C07K 16/18 (2006.01) C07K 16/46 (2006.01) C12N 1/15 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01)
Patent
CA 2750836
Provided is a pharmaceutical composition for treating and/or preventing abnormal bone metabolism targeting a protein encoded by a gene strongly expressed in osteoclasts. Specifically provided is a pharmaceutical composition containing an antibody which specifically recognizes human Siglec-15 and has an activity of inhibiting osteoclast formation, and the like.
L'invention concerne une composition pharmaceutique destinée à traiter et/ou à prévenir des anomalies du métabolisme osseux, et qui cible une protéine codée par un gène pouvant être exprimé fortement dans des ostéoclastes. L'invention concerne spécifiquement, entre autres, une composition pharmaceutique contenant un anticorps capable de reconnaître spécifiquement une protéine Siglec-15 humaine et qui possède une activité d'inhibition de la formation d'ostéoclastes.
Hiruma Yoshiharu
Nakayama Makiko
Takizawa Takeshi
Tsuda Eisuke
Daiichi Sankyo Company Limited
Marks & Clerk
LandOfFree
Anti-siglec-15 antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-siglec-15 antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-siglec-15 antibody will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1918843